• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

THC Appendix 3B26/03/19
THC Canadian Cannabis Production Site Acquisition CompletedPRICE SENSITIVE26/03/19
THC Trading HaltPRICE SENSITIVE25/03/19
THC Preliminary Final ReportPRICE SENSITIVE28/02/19
THC THC Global Corporate Update - January 2019 & App 4CPRICE SENSITIVE31/01/19
THC Appendix 3B15/01/19
THC Appointment of Group Chief Financial Officer15/01/19
THC Cannabis Permits Granted to THC GlobalPRICE SENSITIVE21/12/18
THC Trading HaltPRICE SENSITIVE19/12/18
THC THC Global Expands into New Zealand Med Cannabis MarketPRICE SENSITIVE28/11/18
THC Issue of Securities Following Shareholder Approval & Apps 3Y28/11/18
THC Appendix 3B28/11/18
THC Change of Name to THC Global Group Limited22/11/18
THC Canadian Cannabis Growing Facility Binding Agreement SignedPRICE SENSITIVE16/11/18
THC Results of Meeting15/11/18
THC First Australian Patients Prescribed Endoca CBD ProductsPRICE SENSITIVE02/11/18
THC THC Quarterly Update and Appendix 4CPRICE SENSITIVE31/10/18
THC Performance Shares - Claims received from holders17/10/18
THC THC Positioned for Canadian Recreational CannabisPRICE SENSITIVE16/10/18
THC THC Investor UpdatePRICE SENSITIVE11/10/18
THC Notice of Extraordinary General Meeting/Proxy Form11/10/18
THC Appendix 3B13/09/18
THC Half Yearly Report and AccountsPRICE SENSITIVE30/08/18
THC Change of Company Secretary and Registered Company Offices30/08/18
THC Australian Patients Can Now Access Endoca Medicinal CannabisPRICE SENSITIVE31/07/18
THC Appendix 3B31/07/18
THC June Quarterly Cashflow ReportPRICE SENSITIVE30/07/18
THC Canadian Hydroponics Division and Restatement of ObjectivesPRICE SENSITIVE30/07/18
THC THC Company Presentation - July 201825/07/18
THC THC Secures Northern NSW Site and Off-Take AgreementsPRICE SENSITIVE24/07/18
THC Appendix 3Y - Xu16/07/18
THC Appendix 3Y - Cattelan13/07/18
THC Appendix 3Y - Radcliff12/07/18
THC Acquisition Delivers $16m to Balance Sheet & MC StrategyPRICE SENSITIVE11/07/18
THC Appendix 3B11/07/18
THC THC Appoints CEO & Experienced Medicinal Cannabis TeamPRICE SENSITIVE11/07/18
THC THC Executes Initial Cooperation Agreement With EndocaPRICE SENSITIVE09/07/18
THC THC North American UpdatePRICE SENSITIVE06/07/18
THC Appendix 3B06/07/18
THC Appendix 3B05/07/18
THC Due Diligence Period Extended For Organic Cannabis Site03/07/18
THC EVE: Update on THC AgreementsPRICE SENSITIVE03/07/18
THC Cannabis Strains Exchange with Canadian Licensed ProducerPRICE SENSITIVE28/06/18
THC Appointment of Product & Regulatory Affairs Manager26/06/18
THC Inaugural Medicinal Cannabis Shipment Received from EndocaPRICE SENSITIVE25/06/18
THC Canada Cannabis Bill Passed21/06/18
THC THC REC READY - Canada Passes Cannabis Law08/06/18
THC Appendix 3B08/05/18
THC THC Australian Operations UpdatePRICE SENSITIVE07/05/18
THC Updated Appendix 3B and Statement of Placement Capacity04/05/18
THC Australian Canadian Clinic Rollout HaltedPRICE SENSITIVE04/05/18
THC EVE: Meluka Health and THC Execute Term Sheet03/05/18
THC THC Secures Additional Site for Medicinal Cannabis GrowthPRICE SENSITIVE03/05/18
THC Business UpdatePRICE SENSITIVE27/04/18
THC Reinstatement to Official QuotationPRICE SENSITIVE26/04/18
THC THC Acquires Australian Biomanufacturing FacilityPRICE SENSITIVE26/04/18
THC Appendix 4C - March QuarterlyPRICE SENSITIVE26/04/18
THC Release of Shares from Escrow26/04/18
THC Suspension from Official QuotationPRICE SENSITIVE24/04/18
THC Trading HaltPRICE SENSITIVE20/04/18
THC Shareholder Update - Executive Team Appointed12/04/18
THC Change of Director's Interest Notice - G Radcliff29/03/18
THC Appendix 3B29/03/18
THC Results of Annual General Meeting23/03/18
THC AGM Chairman's Address to Shareholders23/03/18
THC AGM Shareholder Presentation23/03/18
THC Appendix 3B19/03/18
THC 2018 AGM Update and Revised Proxy Forms16/03/18
THC Initial Director's Interest Notice - Lou Cattelan16/03/18
THC Initial Director's Interest Notice - Gary Radcliff16/03/18
THC Final Director's Interest Notice x 416/03/18
THC Results of EGMPRICE SENSITIVE15/03/18
THC Trading HaltPRICE SENSITIVE15/03/18
THC Resignation of Chief Executive OfficerPRICE SENSITIVE14/03/18
THC Resignation of Chief Commercial Officer13/03/18
THC Appendix 3B08/03/18
THC Appendix 3B06/03/18
THC Appendix 4G06/03/18
THC 2017 Annual Report02/03/18
THC THC Welcomes Simplified Access to Medicinal Cannabis in NSW02/03/18
THC Canada UpdatePRICE SENSITIVE02/03/18
THC Appendix 4E - Preliminary Final ReportPRICE SENSITIVE28/02/18
THC Granting of Endoca Import Permits and Clinical Trial SupportPRICE SENSITIVE28/02/18
THC Appendix 3B22/02/18
THC Queensland Growing Facility Update15/02/18
THC Notice of Inaugural Annual General Meeting and Proxy Forms13/02/18
THC ASIC Consent to Extension of Time to Hold Inaugural AGM08/02/18
THC Company Response to EGM Notice Issued by Alan BeasleyPRICE SENSITIVE08/02/18
THC Clinic Rollout UpdatePRICE SENSITIVE07/02/18
THC Chairman's Letter and Notice of Meeting from A Beasley06/02/18
THC Change in substantial holding06/02/18
THC Change in substantial holding05/02/18
THC Change in substantial holding05/02/18
THC Change of Director's Interest Notice - I Mutton02/02/18
THC Change of Director's Interest Notice - H Macdonald02/02/18
THC Change of Director's Interest Notice - P Wallace02/02/18
THC Quarterly Company Update31/01/18
THC Appendix 4C - December QuarterlyPRICE SENSITIVE31/01/18
THC Appendix 3B29/01/18
THC Canadian Business UpdatePRICE SENSITIVE24/01/18
THC Appendix 3B
26/03/19
THC Canadian Cannabis Production Site Acquisition Completed
26/03/19PRICE SENSITIVE
THC Trading Halt
25/03/19PRICE SENSITIVE
THC Preliminary Final Report
28/02/19PRICE SENSITIVE
THC THC Global Corporate Update - January 2019 & App 4C
31/01/19PRICE SENSITIVE
THC Appendix 3B
15/01/19
THC Appointment of Group Chief Financial Officer
15/01/19
THC Cannabis Permits Granted to THC Global
21/12/18PRICE SENSITIVE
THC Trading Halt
19/12/18PRICE SENSITIVE
THC THC Global Expands into New Zealand Med Cannabis Market
28/11/18PRICE SENSITIVE
THC Issue of Securities Following Shareholder Approval & Apps 3Y
28/11/18
THC Appendix 3B
28/11/18
THC Change of Name to THC Global Group Limited
22/11/18
THC Canadian Cannabis Growing Facility Binding Agreement Signed
16/11/18PRICE SENSITIVE
THC Results of Meeting
15/11/18
THC First Australian Patients Prescribed Endoca CBD Products
02/11/18PRICE SENSITIVE
THC THC Quarterly Update and Appendix 4C
31/10/18PRICE SENSITIVE
THC Performance Shares - Claims received from holders
17/10/18
THC THC Positioned for Canadian Recreational Cannabis
16/10/18PRICE SENSITIVE
THC THC Investor Update
11/10/18PRICE SENSITIVE
THC Notice of Extraordinary General Meeting/Proxy Form
11/10/18
THC Appendix 3B
13/09/18
THC Half Yearly Report and Accounts
30/08/18PRICE SENSITIVE
THC Change of Company Secretary and Registered Company Offices
30/08/18
THC Australian Patients Can Now Access Endoca Medicinal Cannabis
31/07/18PRICE SENSITIVE
THC Appendix 3B
31/07/18
THC June Quarterly Cashflow Report
30/07/18PRICE SENSITIVE
THC Canadian Hydroponics Division and Restatement of Objectives
30/07/18PRICE SENSITIVE
THC THC Company Presentation - July 2018
25/07/18
THC THC Secures Northern NSW Site and Off-Take Agreements
24/07/18PRICE SENSITIVE
THC Appendix 3Y - Xu
16/07/18
THC Appendix 3Y - Cattelan
13/07/18
THC Appendix 3Y - Radcliff
12/07/18
THC Acquisition Delivers $16m to Balance Sheet & MC Strategy
11/07/18PRICE SENSITIVE
THC Appendix 3B
11/07/18
THC THC Appoints CEO & Experienced Medicinal Cannabis Team
11/07/18PRICE SENSITIVE
THC THC Executes Initial Cooperation Agreement With Endoca
09/07/18PRICE SENSITIVE
THC THC North American Update
06/07/18PRICE SENSITIVE
THC Appendix 3B
06/07/18
THC Appendix 3B
05/07/18
THC Due Diligence Period Extended For Organic Cannabis Site
03/07/18
THC EVE: Update on THC Agreements
03/07/18PRICE SENSITIVE
THC Cannabis Strains Exchange with Canadian Licensed Producer
28/06/18PRICE SENSITIVE
THC Appointment of Product & Regulatory Affairs Manager
26/06/18
THC Inaugural Medicinal Cannabis Shipment Received from Endoca
25/06/18PRICE SENSITIVE
THC Canada Cannabis Bill Passed
21/06/18
THC THC REC READY - Canada Passes Cannabis Law
08/06/18
THC Appendix 3B
08/05/18
THC THC Australian Operations Update
07/05/18PRICE SENSITIVE
THC Updated Appendix 3B and Statement of Placement Capacity
04/05/18
THC Australian Canadian Clinic Rollout Halted
04/05/18PRICE SENSITIVE
THC EVE: Meluka Health and THC Execute Term Sheet
03/05/18
THC THC Secures Additional Site for Medicinal Cannabis Growth
03/05/18PRICE SENSITIVE
THC Business Update
27/04/18PRICE SENSITIVE
THC Reinstatement to Official Quotation
26/04/18PRICE SENSITIVE
THC THC Acquires Australian Biomanufacturing Facility
26/04/18PRICE SENSITIVE
THC Appendix 4C - March Quarterly
26/04/18PRICE SENSITIVE
THC Release of Shares from Escrow
26/04/18
THC Suspension from Official Quotation
24/04/18PRICE SENSITIVE
THC Trading Halt
20/04/18PRICE SENSITIVE
THC Shareholder Update - Executive Team Appointed
12/04/18
THC Change of Director's Interest Notice - G Radcliff
29/03/18
THC Appendix 3B
29/03/18
THC Results of Annual General Meeting
23/03/18
THC AGM Chairman's Address to Shareholders
23/03/18
THC AGM Shareholder Presentation
23/03/18
THC Appendix 3B
19/03/18
THC 2018 AGM Update and Revised Proxy Forms
16/03/18
THC Initial Director's Interest Notice - Lou Cattelan
16/03/18
THC Initial Director's Interest Notice - Gary Radcliff
16/03/18
THC Final Director's Interest Notice x 4
16/03/18
THC Results of EGM
15/03/18PRICE SENSITIVE
THC Trading Halt
15/03/18PRICE SENSITIVE
THC Resignation of Chief Executive Officer
14/03/18PRICE SENSITIVE
THC Resignation of Chief Commercial Officer
13/03/18
THC Appendix 3B
08/03/18
THC Appendix 3B
06/03/18
THC Appendix 4G
06/03/18
THC 2017 Annual Report
02/03/18
THC THC Welcomes Simplified Access to Medicinal Cannabis in NSW
02/03/18
THC Canada Update
02/03/18PRICE SENSITIVE
THC Appendix 4E - Preliminary Final Report
28/02/18PRICE SENSITIVE
THC Granting of Endoca Import Permits and Clinical Trial Support
28/02/18PRICE SENSITIVE
THC Appendix 3B
22/02/18
THC Queensland Growing Facility Update
15/02/18
THC Notice of Inaugural Annual General Meeting and Proxy Forms
13/02/18
THC ASIC Consent to Extension of Time to Hold Inaugural AGM
08/02/18
THC Company Response to EGM Notice Issued by Alan Beasley
08/02/18PRICE SENSITIVE
THC Clinic Rollout Update
07/02/18PRICE SENSITIVE
THC Chairman's Letter and Notice of Meeting from A Beasley
06/02/18
THC Change in substantial holding
06/02/18
THC Change in substantial holding
05/02/18
THC Change in substantial holding
05/02/18
THC Change of Director's Interest Notice - I Mutton
02/02/18
THC Change of Director's Interest Notice - H Macdonald
02/02/18
THC Change of Director's Interest Notice - P Wallace
02/02/18
THC Quarterly Company Update
31/01/18
THC Appendix 4C - December Quarterly
31/01/18PRICE SENSITIVE
THC Appendix 3B
29/01/18
THC Canadian Business Update
24/01/18PRICE SENSITIVE
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.